Prognostic significance of pituitary tumour-transforming gene-binding factor (PBF) expression in papillary thyroid carcinoma

Clinical Endocrinology

Volumn 78, Issue 2, 2013, Pages 303-309

  Hsueh, Chuen ^a   Lin, Jen Der ^a   Chang, Yu Sun ^a   Hsueh, Swei ^a   Chao, Tzu Chieh ^a   Yu, Jau Song ^a   Jung, Shih Ming ^a   Tseng, Ngan Ming ^a   Sun, Jui Hung ^a   Kuo, Shau Yun ^a   Ueng, Shir Hwa ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131; SECURIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPOPHYSIS TUMOR; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIPLE CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; THYROID CARCINOMA; TISSUE SECTION; TUMOR VOLUME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, PAPILLARY; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PROGNOSIS; THYROID NEOPLASMS; YOUNG ADULT;

EID: 84872121127     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/cen.12007     Document Type: Article

References (27)

1. Davies, L., &, Welch, H.G., (2006) Increasing incidence of thyroid cancer in the United States, 1973-2002. Journal of the American Medical Association, 295, 2164-2167.
2. Mazzaferri, E.L., &, Kloos, R.T., (2001) Clinical review 128: current approaches to primary therapy for papillary and follicular thyroid cancer. Journal of Clinical Endocrinology and Metabolism, 86, 1447-1463.
3. Hay, I.D., Thompson, G.B., Grant, C.S., et al,. (2002) Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients. World Journal of Surgery, 26, 879-885.
4. Xing, M., (2007) BRAF mutation in papillary thyroid cancer: pathogenic role, molecular bases, and clinical implications. Endocrine Reviews, 28, 742-762.
5. Chien, W., &, Pei, L., (2000) A novel binding factor facilitates nuclear translocation and transcriptional activation function of the pituitary tumor-transforming gene product. Journal of Biological Chemistry, 275, 19422-19427.
6. Yaspo, M.L., Aaltonen, J., Horelli-Kuitunen, N., et al,. (1998) Cloning of a novel human putative type Ia integral membrane protein mapping to 21q22.3. Genomics, 49, 133-136.
7. Pei, L., &, Melmed, S., (1997) Isolation and characterization of a pituitary tumor-transforming gene (PTTG). Molecular Endocrinology, 11, 433-441.
8. Zou, H., McGarry, T.J., Bernal, T., et al,. (1999) Identification of a vertebrate sister-chromatid separation inhibitor involved in transformation and tumorigenesis. Science, 285, 418-422.
9. Boelaert, K., Smith, V.E., Stratford, A.L., et al,. (2007) PTTG and PBF repress the human sodium iodide symporter. Oncogene, 26, 4344-4356.
10. Vlotides, G., Eigler, T., &, Melmed, S., (2007) Pituitary tumor-transforming gene: physiology and implications for tumorigenesis. Endocrine Reviews, 28, 165-186.
11. McCabe, C.J., Khaira, J.S., Boelaert, K., et al,. (2003) Expression of pituitary tumour transforming gene (PTTG) and fibroblast growth factor-2 (FGF-2) in human pituitary adenomas: relationships to clinical tumour behaviour. Clincal Endocrinology (Oxford), 58, 141-150.
12. Stratford, A.L., Boelaert, K., Tannahill, L.A., et al,. (2005) Pituitary tumor transforming gene binding factor: a novel transforming gene in thyroid tumorigenesis. Journal of Clinical Endocrinology and Metabolism, 90, 4341-4349.
13. LiVolsi, V.A., Mazzaferri, E.L., Schneider, A.B., et al,. (2004) Papillary carcinoma. In:, R.A. Delellis, R.V. Lloyd, P.U. Heitz, et al. eds. World Health Organization Classification of Tumors, Pathology and Genetics of Tumors of Endocrine Organs, International Agency for Research on Cancer, Lyon, 57-66.
14. Kirkegaard, T., Edwards, J., Tovey, S., et al,. (2006) Observer variation in immunohistochemical analysis of protein expression, time for a change? Histopathology, 48, 787-794.
15. Lin, J.D., Chao, T.C., Hsueh, C., et al,. (2009) High recurrent rate of multi-centric papillary thyroid carcinoma. Annals of Surgical Oncology, 16, 2609-2616.
16. Lin, J.D., Hsueh, C., &, Chao, T.C., (2009) Early recurrence papillary and follicular thyroid carcinoma predicts a worse outcome. Thyroid, 19, 1053-1058.
17. Smith, V.E., Read, M.L., Turnell, A.S., et al,. (2009) A novel mechanism of sodium iodide symporter repression in differentiated thyroid cancer. Journal of Cell Science, 122, 3393-3402.
18. Watkins, R.J., Read, M.L., Smith, V.E., et al,. (2010) Pituitary tumor transforming gene binding factor: a new gene in breast cancer. Cancer Research, 70, 3739-3749.
19. Boelaert, K., McCabe, C.J., Tannahill, L.A., et al,. (2003) Pituitary tumor transforming gene and fibroblast growth factor-2 expression: potential prognostic indicators in differentiated thyroid cancer. Journal of Clinical Endocrinology and Metabolism, 88, 2341-2347.
20. Saez, C., Martinez-Brocca, M.A., Castilla, C., et al,. (2006) Prognostic significance of human pituitary tumor-transforming gene immunohistochemical expression in differentiated thyroid cancer. Journal of Clinical Endocrinology and Metabolism, 91, 1404-1409.
21. Heaney, A.P., Nelson, V., Fernando, M., et al,. (2001) Transforming events in thyroid tumorigenesis and their association with follicular lesions. Journal of Clinical Endocrinology and Metabolism, 86, 5025-5032.
22. McCabe, C.J., Boelaert, K., Tannahill, L.A., et al,. (2002) Vascular endothelial growth factor (VEGF), its receptor KDR and pituitary tumor transforming gene in pituitary tumors. The Journal of Clinical Endocrinology and Metabolism, 87, 4238-4244.
23. Kim, D.S., Franklyn, J.A., Stratford, A.L., et al,. (2006) Pituitary tumor-transforming gene regulates multiple downstream angiogenic genes in thyroid cancer. Journal of Clinical Endocrinology and Metabolism, 91, 1119-1128.
24. Ishikawa, H., Heaney, A.P., Yu, R., et al,. (2001) Human pituitary tumor-transforming gene induces angiogenesis. Journal of Clinical Endocrinology and Metabolism, 86, 867-874.
25. Zhang, X, Horwitz, G.A., Prezant, T.R., et al,. (1999b) Structure, expression, and function of human pituitary tumor-transforming gene (PTTG). Molecular Endocrinology 13, 156-166.
26. Read, M.L., Lewy, G.D., Fong, J.C., et al,. (2011) Proto-oncogene PBF/PTTG1IP regulates thyroid cell growth and represses radioiodide treatment. Cancer Research, 71, 6153-6164.
27. Bork, P., Doerks, T., Springer, T.A., et al,. (1999) Domains in plexins: links to integrins and transcription factors. Trends in Biochemical Sciences, 24, 261-263.